Evidence map›Paper›PMID 32940599›Full record

ArticleeLife2020

MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression.

Timothy J Aikin, Amy F Peterson, Michael J Pokrass, Helen R Clark, Sergi Regot

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Beyond the membrane: rethinking EGFR signaling in physiology and cancer.Cellular and molecular life sciences : CMLS · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Two novel red-FRET ERK bosensors in the 670-720 nm range.Journal of biological engineering · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. pERK transition-induced directional mode switching promotes epithelial tumor cell migration.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Timothy J AikinDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0003-4594-1691
Amy F PetersonDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0002-0848-8181
Michael J PokrassDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0002-9603-4189
Helen R ClarkDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0002-2035-9796
Sergi RegotDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0001-9786-3897
Johns Hopkins University · US

Funding

BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
Single Cell Analysis of MAPK Signaling Dynamics in MulticellularityR35GM133499 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Sergi Regot · 2019 to 2026
$3.3M
NIGMS NIH HHS 1 R35 GM133499NIGMS NIH HHS R35 GM133499NIGMS NIH HHS T32 GM007445
6 · The paper itself

Abstract

A large fraction of human cancers contain genetic alterations within the Mitogen Activated Protein Kinase (MAPK) signaling network that promote unpredictable phenotypes. Previous studies have shown that the temporal patterns of MAPK activity (i.e. signaling dynamics) differentially regulate cell behavior. However, the role of signaling dynamics in mediating the effects of cancer driving mutations has not been systematically explored. Here, we show that oncogene expression leads to either pulsatile or sustained ERK activity that correlate with opposing cellular behaviors (i.e. proliferation vs. cell cycle arrest, respectively). Moreover, sustained-but not pulsatile-ERK activity triggers ERK activity waves in unperturbed neighboring cells that depend on the membrane metalloprotease ADAM17 and EGFR activity. Interestingly, the ADAM17-EGFR signaling axis coordinates neighboring cell migration toward oncogenic cells and is required for oncogenic cell extrusion. Overall, our data suggests that the temporal patterns of MAPK activity differentially regulate cell autonomous and non-cell autonomous effects of oncogene expression.

Indexed as

ADAM17 ProteinCell Line, TumorErbB ReceptorsGene Expression Regulation, NeoplasticHumansMAP Kinase Signaling SystemMitogen-Activated Protein KinasesMutationNeoplasmsOncogenesADAM17 ProteinADAM17 protein, humanEGFR protein, humanErbB ReceptorsMitogen-Activated Protein Kinasesbiosensorscancer biologycell biologyhumanlive-cell imagingsignaling dynamics

Identifiers

PMID32940599
PMCPMC7498266
OpenAlexW3086325855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.